In this study, however, we have demonstrated that the four ovarian cancer cell lines resistant to cis-Pt, irrespective of p53 genotype, were responsive to oxali-Pt and demonstrated low cross-resistance to this Pt analog. Here, TP53 is linked to ovarian cancer.